EUVIMEDEUVIMED entdecken
Crossref

Dynamic Size‐Change Nanovaccine for Enhancing Lymph Node Deep Penetration and Eliciting Robust Antitumor Immune Responses

Liping Liu, Zichao Huang, Zhenyi Zhu, Aolin Sun, Jiayu Zhao, Yudi Xu, Wantong Song iD, Zhaohui Tang iD, Xuesi Chen

Advanced Materials · 2025

DOI: 10.1002/adma.202504909 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, 2025. Verfasst von Liping Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Polymer Science and Technology, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, Chi…. Hauptthemen laut MEDLINE: Lymph Nodes, Cancer Vaccines, Nanoparticles. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key R&D Program of China, Jilin Province Science and Technology Development Plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breakthrough advances in nanotechnology have substantially enhanced lymph node (LN) targeting efficiency and immune cell uptake of nanovaccines, establishing novel avenues for tumor immunotherapy. Nevertheless, current nanovaccines predominantly accumulate in subcapsular sinuses (SCS) or superficial cortical regions post‐lymphatic transport, failing to traverse anatomical barriers to reach the T cell‐enriched paracortex—a critical delivery bottleneck that severely limits full activation of cellular immunity. Furthermore, the absence of tumor‐specific endogenous stimuli in LN microenvironments invalidates conventional environment‐responsive delivery strategies. Herein, “ d yn a mically s ize‐c h ange nanovaccine” (DashVax), a time‐controlled self‐disassembling nanovaccine is presented that achieves dynamic size transition from 102 to 5 nm via physiologically regulated imine bond hydrolysis. This design capitalizes on the lymphatic drainage superiority of large particles and tissue‐penetrating capacity of small units, achieving a breakthrough 7.3‐fold enhancement in paracortical antigen delivery compared to non‐size‐change nanovaccines (NoncVax). DashVax demonstrates robust antigen‐specific immune responses and tumor growth suppression in both B16‐OVA and MC38 tumor models. This exogenous stimulus‐free temporal delivery strategy not only redefines nanovaccine design principles but also elucidates fundamental correlations between intranodal delivery kinetics and immune activation efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymph NodesCancer VaccinesNanoparticlesAnimalsMiceCell Line, TumorMice, Inbred C57BLParticle SizeImmunotherapyNanovaccines

Stichwörter der Autor:innen

dynamic covalent bondsnanotechnologysize‐changetumor therapyvaccine

Substanzen

Cancer VaccinesNanovaccines

Autor:innen und Institutionen

  • State Key Laboratory of Polymer Science and Technology, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, China.
  • School of Applied Chemistry and Engineering, University of Science and Technology of China, Hefei, 230026, China.
  • Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, China.
  • Jilin Biomedical Polymers Engineering Laboratory, Changchun, 130022, China.

ORCID-Profile: Wantong Song, Zhaohui Tang

Förderung

  • National Natural Science Foundation of China
  • National Key R&D Program of China
  • Jilin Province Science and Technology Development Plan
  • Jilin Provincial International Cooperation Key Laboratory of Biomedical Polymers
  • National Key Research and Development Program of China

Zitieren

APA

Liu, L., Huang, Z., Zhu, Z., Sun, A., Zhao, J., Xu, Y., Song, W., Tang, Z., & Chen, X. (2025). Dynamic Size‐Change Nanovaccine for Enhancing Lymph Node Deep Penetration and Eliciting Robust Antitumor Immune Responses. Advanced Materials. https://doi.org/10.1002/adma.202504909

Vancouver

Liu L, Huang Z, Zhu Z, Sun A, Zhao J, Xu Y, et al. Dynamic Size‐Change Nanovaccine for Enhancing Lymph Node Deep Penetration and Eliciting Robust Antitumor Immune Responses. Advanced Materials. 2025. doi:10.1002/adma.202504909

BibTeX
@article{Liu2025,
  author = {Liu, Liping and Huang, Zichao and Zhu, Zhenyi and Sun, Aolin and Zhao, Jiayu and Xu, Yudi and Song, Wantong and Tang, Zhaohui and Chen, Xuesi},
  title = {Dynamic Size‐Change Nanovaccine for Enhancing Lymph Node Deep Penetration and Eliciting Robust Antitumor Immune Responses},
  journal = {Advanced Materials},
  year = {2025},
  doi = {10.1002/adma.202504909}
}
Kostenlos starten →